Accessibility Menu
HeartBeam logo

HeartBeam(NASDAQ) BEAT

Market Cap$27.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-89%
5 YearN/A
1 Year-50%
1 Month-31%
$0.50
-0.12%
-0.00Today
HeartBeam last closing stock price
MetricPriceDate
Last closeUSD 0.502026-08-04
HeartBeam stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.8%USD 0.532026-07-28
1 month-31.03%USD 0.722026-07-02
3 month-41.99%USD 0.862026-05-06
Year to date-79.31%USD 2.402025-12-31
1 year-50.34%USD 1.002025-08-04
3 year-82.76%USD 2.882023-08-04
Since inception-89.41%USD 4.692021-11-11

HeartBeam Financials at a Glance

Market Cap

$27.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$20.23M

EPS (TTM)

-$0.56

P/E Ratio

-0.88

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.50

Volume

387,124

Open

$0.50

Previous Close

$0.50

Daily Range

$0.49 - $0.51

52-Week Range

$0.48 - $4.00

Estimated Earnings Date

Aug 13, 2026

BEAT News

featured-earnings-leadership-highlights.png

HeartBeam Cuts Costs Awaits FDA Decision

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartBeam

HeartBeam helps doctors monitor heart health remotely using a small device and software. Its system lets patients record heart data at home, sending results to their doctors. This approach aims to make heart care more accessible for people outside hospitals.

Gadgets and Gizmos: What HeartBeam Sells

  • HeartBeam System: Portable, credit card-sized device for recording heart signals at home (0% of revenue in Q2 2025).
  • Cloud-Based Software: Diagnostic platform for doctors to review patient heart data remotely (0% of revenue in Q2 2025).
  • AI Algorithms: Software that turns simple heart readings into detailed, 12-lead electrocardiograms (ECGs) for better diagnosis.
  • Early Access Program: Pilot program for select users to test the system and provide feedback (no revenue generated).
  • Automated ECG Interpretation: Partnership with AccurKardia to add automatic heart rhythm analysis for doctors.

Growth Spurts and Strategic Moves

  • Received FDA clearance for HeartBeam System in December 2024.
  • Submitted 12-lead ECG software for regulatory review in January 2025.
  • Launched Early Access Program in early 2025 to gather user feedback.
  • Formed partnership with AccurKardia in April 2025 for automated ECG analysis.
  • Expanded patent portfolio to 16 U.S. and 6 international patents by June 2025.

Why HeartBeam Is a Bit Different

HeartBeam’s device collects heart data in three dimensions, allowing for detailed analysis outside clinics. Its software can create a full 12-lead ECG from a simple home device, which is rare in remote monitoring. The company’s focus on intellectual property and partnerships supports its position in the telehealth market.

Five Things You Need to Know

  • Revenue was $0 in Q2 2025, unchanged from Q2 2024 and Q2 2023.
  • Operating loss was $5 million in Q2 2025, a 1% increase year-over-year.
  • Cash and short-term investments totaled $5.1 million as of June 30, 2025.
  • Net cash used in operations was $7.9 million for the first half of 2025.
  • The company relies on equity raises for funding.

Bottom Line

HeartBeam is an early-stage company focused on remote heart monitoring technology. It faces ongoing losses and depends on new funding to continue operations.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16

CEO

Robert P. Eno, MBA

Website

www.heartbeam.com

Headquarters

Santa Clara, CA 95050, US

BEAT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-1034.04%

Return on Capital

-812.10%

Return on Assets

-514.91%

Earnings Yield

-1.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

55.51M

Volume

387.12K

Avg. Volume

789.91K

Financials (TTM)

Gross Profit

-$24.00K

Operating Income

-$20.35M

EBITDA

-$20.17M

Operating Cash Flow

-$13.12M

Capital Expenditure

-$846.00K

Free Cash Flow

-$13.97M

Cash & ST Invst.

$2.04M

Total Debt

$0.00

HeartBeam Performance Analysis

HeartBeam annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
HeartBeam sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
HeartBeam annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.59179.9%
20232023-12-31USD -0.72-54.6%
20242024-12-31USD -0.731.4%
20252025-12-31USD -0.62-14.6%
HeartBeam sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3016.7%
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-3120.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$27.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.72M

N/A

Employees

16

N/A

Net Income

-$4.70M

+14.3%

EBITDA

-$4.68M

+14.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.04M

-75.0%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$133.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-5.15%

N/A

Return on Invested Capital

-32.05%

N/A

Free Cash Flow

-$3.86M

+13.9%

Operating Cash Flow

-$3.61M

+19.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRVOCervoMed Inc.
$2.81+0.36%
HOWLWerewolf Therapeutics, Inc.
$0.40-3.04%
ONMDOneMedNet Corporation
$0.65-9.39%
MDAISpectral AI, Inc.
$1.63-1.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.27-0.14%
NVDANvidia
$219.22+0.03%
ONDSOndas
$8.87+0.00%
PATHUiPath
$13.82-0.02%

Questions About BEAT

What is the current price of HeartBeam?

HeartBeam is trading at $0.50 per share.

What is the 52-week range for HeartBeam?

Over the past 52 weeks, HeartBeam has traded between $0.48 and $4.00.

How much debt does HeartBeam have?

As of the most recent reporting period, HeartBeam reported total debt of $0.00.

How much cash does HeartBeam have on hand?

HeartBeam reported $2.04M in cash and cash equivalents in its most recent financial results.

What is HeartBeam’s dividend yield?

HeartBeam does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services